Construction and application of a kind of HVT co-expressing ndv HN and IBDV VP2 genes
A co-expression and gene technology, applied in the field of animal biological products, can solve problems such as increasing the cost of vaccines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] ——Construction of recombinant virus rHVT-HN
[0038] 1. Construction of recombinant plasmid PHVT-DS
[0039] First construct a recombinant plasmid for homologous recombination, which contains homologous sequences on both sides of the US2 gene, and primers (SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8);
[0040] HVT-US2 left sense: 5-GATgaattcA CATCGGGCCA CGTTCCGCC-3 29 (SEQ ID NO: 5);
[0041] HVT-US2 left antisense: 5-ATAGTCGACt taattaaGAT GAGCTGACGT GTGGAAT-337 (SEQ ID NO: 6).
[0042] HVT-US2 right sense: 5-ATCgtcgacA CTAATATGGG CACACCCAC-3 29 (SEQ ID NO: 7);
[0043] HVT-US2 right antisense: 5-ATCaagcttT GGCCCATCTA GGTGATTAT-3 29 (SEQ ID NO: 8).
[0044] The HVT genome was used as a template for amplification, and the amplified left and right arm sequences were cloned into PUC18 through restriction sites. The cloned recombinant plasmid containing the left and right arms was named PHVT-DS.
[0045] 2. Construction of PHVT-DS-NDV-HN
[0046] Accordin...
Embodiment 2
[0052] ——Construction of recombinant turkey herpesvirus rHVT-HN-VP2
[0053] The recombinant virus rHVT-HN was used as a carrier platform to express the VP2 gene of chicken infectious bursal virus (IBDV). The specific construction method is as follows:
[0054] Extract the HVT virus genomic DNA according to conventional methods, according to the full gene sequence of the HVT-FC126 strain (GenBank: AF291866.1) published in Genebank, design primers (sequence 9 and sequence 10) to amplify the left homology arm and connect to PMD19-Tsimple Vector, constructed into plasmid pMD19-L. Primers (Sequence 11 and Sequence 12) were designed to amplify the promoter (Sequence 2), and the promoter was cloned into PMD19-L to construct plasmid PMD19-L-PRO. Then design primers (SEQ ID NO: 13 and SEQ ID NO: 14) to amplify the VP2 gene (SEQ ID NO: 3), clone the VP2 gene into PMD19-L-PRO, and construct the plasmid PMD19-L-PRO-VP2. Design primers (sequence 15 and sequence 16) to amplify PolyA (se...
Embodiment 3
[0070] ——Validation of Recombinant Viruses
[0071] 1. rHVT-HN recombinant virus
[0072] 50PFU of rHVT-HN and HVT were inoculated on 12-well cell culture plates. After obvious plaques appeared in culture, pour out the growth medium, fix with cold acetone:ethanol (3:2) fixative solution for 10 min, wash once with PBS, add 0.5 mL (1:100 Diluted) anti-NDV single-factor serum, placed in a constant temperature incubator at 37°C for 1 hour, washed 3 times with PBS, added 0.5mL FITC-labeled anti-IgG fluorescent antibody to each well, placed in a constant temperature biochemical incubator at 37°C, and reacted for 1 hour, After washing with PBS for 3 times, observed under an inverted fluorescence microscope, the plaques showed specific green fluorescence, while the CEF cells in the control group had no fluorescence after HVT infection. The results indicated that the NDV-HN gene could be well and correctly expressed.
[0073] 2. rHVT-HN-VP2 recombinant virus
[0074] Inoculate 50PFU...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com